Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Ministry of Science and Technology, Taiwan
Grant: 111-2320-B-182-018
the Ministry of Science and Technology, Taiwan
Grant: 109-2314-B-182A-097-MY3
the Ministry of Science and Technology, Taiwan
Grant: 112-2320-B-182-018
the Ministry of Science and Technology, Taiwan
Grant: CMRPD1M0581
the Ministry of Science and Technology, Taiwan
Grant: CMRPD1M0582
the Ministry of Science and Technology, Taiwan
Grant: BMRPC17
National Cancer Institute, Center for Cancer Research
Grant: Intramural Research Program of the National Institutes of Health
the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research
Fields of Study
MeSH Terms
Keywords